Dual therapy with metformin and SGLT2 inhibitors should be offered to all people newly diagnosed with type 2 diabetes, draft NICE guidance says.
by
Dawn Liz Powell
NICE backs SGLT2 inhibitors as first-line type 2 diabetes therapy in major shake-up
